Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2020

Sep 25, 2020

32566_dirs_2020-09-25_5724053f-690f-4a53-89b1-6aed1248a13a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-09-24

Reporting Person: Parkinson Paul (EVP Strategy and Innovation)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 76821 Direct